Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
To facilitate this transition from observational findings to clinical application, large-scale randomized clinical trials are essential
This is what personal health tracking makes possible: informed decisions instead of guesses
Clinical trials and NICE evidence reviews have demonstrated that GLP-1 receptor agonists can reduce HbA1c (a measure of average blood glucose over three months) by approximately 1.01.5 percentage points in people with type 2 diabetes
Because when you do that, weight loss happens naturally
Lancet Diabetes Endocrinol 9(10):653662 Marso SP, Bain SC, Consoli A et al (2016) Semaglutide and cardiovascular outcomes in patients with type 2 diabetes
US$ 21.99
US$ 27.98
US$ 29.07
US$ 27.57
US$ 22.46
